Dr Katherin M. Duthie joins Ethics Talk to discuss her article, coauthored with Dr Kathryn A. Dong: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?”
Theodore E. Schall, PhD, MSW, MBE, Kaitlyn Jaffe, PhD, and Jacob D. Moses, PhD
Clinicians should know how randomized controlled trials can and cannot contribute to advancing health equity for transgender and gender diverse people.
AMA J Ethics. 2024;26(9):E684-689. doi:
10.1001/amajethics.2024.684.